Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04053296
Status:
UNKNOWN
Last Update Posted:
2019-08-12
First Post:
2019-08-09
Brief Title:
Long-term Outcomes of Pregnant Women With PAH
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Study Overview
Official Title:
Morbidity and Outcomes of Pregnant Women With Pulmonary Arterial Hypertension During Different Pregnancies
Status:
UNKNOWN
Status Verified Date:
2019-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators intend to explore the characteristics and outcomes of pregnant women with PAH during different pregnancies and to provide applicable evidence for clinical practice
Detailed Description:
Pulmonary arterial hypertension PAH is a fatal disease with progressive vascular resistance that leads to the loss of right heart function Avoiding pregnancy is essential for PAH women In recent years maternal mortality in pregnant women with PAH has decreased mostly due to emerging advanced therapies for PAH and the progress in high-risk pregnancy management Nevertheless the maternal death rate in parturients with PAH remains high therefore contraception is still recommended for women diagnosed with PAH However some women develop this condition during pregnancy With the two-child policy families in China are allowed to have a second child As a result the number of PAH diagnoses during pregnancy may increase with the general increase in the number of pregnant women Additionally some patients develop PAH only during their second pregnancy In order to investigate the incidence and clinical characteristics of pregnant women diagnosed with PAH during different pregnancies this observational study aimed to analyze perinatal and pregnancy clinical data to compare the perinatal status and maternal and infant outcomes of the first and second pregnancies complicated with PAH establishing a clinical basis for the prenatal consultation diagnosis and treatment of pregnant women with PAH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None